摘要
目的探讨非菌性尿道炎支原体感染及耐药现状,以期为临床用药提供依据。方法对2001-2008年共2532例疑似NGU患者行支原体培养,对阳性患者进行药敏试验。结果2532例疑似NGU患者中支原体阳性1683例(66.47%),其中UU、mH和UU+MH混合感染率分别为1231例(48.62%)、178例(7.03%)、274例(10.82%);耐药率较低的依次为美满霉素、四环素、阿奇霉素。耐药性较高的有甲磺酸培氟沙星、琥钇红霉素。结论支原体是非淋菌尿道炎的主要病原体,临床上应重视支原体检查与药敏试验,合理选择抗生素。应首选美满霉素、四环素、阿奇霉素。
Objective Discusses the non-fungus urethritis mycoplasma infection and bears the medicine present situation, provides the basis take the time as the clinical medication. Method To 2001 -2008 year altogether 2532 example doubtful NGU patient good mycoplasma raise, entered to the masculine patient takes a walk the sensitive experiment. Results In 2532 example doubtful NGU patient the mycoplasma masculine gender 1683 examples (66.47%), in which UU, mH and the UU + MH mix infection percentage respectively is 1231 examples (48.62%), 178 examples (7.03%), 274 examples (10.82%) ; Bears the medicine rate lowly is in turn the content mildew element, the tetracyclin, the arch mildew element. The drug resistance high has the methylsulfonic acid to cultivate fluorine Sha Xing, the amber yttrium erythromycin. Conclusion The mycoplasma right and wrong gonococcus urethritis main pathogen, on clinical should take the mycoplasma inspection and the medicine sensitive experiment, chooses the antibiotic reasonably. Should the first choice content mildew element, the tetracyclin, the arch mildew element.
出处
《中国实用医药》
2009年第5期38-40,共3页
China Practical Medicine
关键词
支原体
非淋菌性尿道炎
药敏试验
Mycoplasma
Non-gonococcus urethritis
Medicine sensitive experiment